Clinical Benefits with Oseltamivir in Treating Influenza in Adult PopulationsResults of a Pooled and Subgroup Analysis

被引：0
|
作者：
S. Singh
J. Barghoorn
A. Bagdonas
J. Adler
J. Treanor
N. Kinnersley
P. Ward
机构：
[1] SARC Research Center,Infectious Diseases Unit
[2] Red Cross Hospital,undefined
[3] University of Rochester,undefined
[4] Roche Global Development,undefined
来源：
Clinical Drug Investigation | 2003年 / 23卷
关键词：
Influenza; Oseltamivir; Influenza Infection; ITTI Population; Accelerate Failure Time Model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：561 / 569
页数：8
相关论文
共 50 条
  • [21] Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data
    W. Joseph Herring
    Kathryn M. Connor
    Ellen Snyder
    Duane B. Snavely
    Ying Zhang
    Jill Hutzelmann
    Deborah Matzura-Wolfe
    Ruth M. Benca
    Andrew D. Krystal
    James K. Walsh
    Christopher Lines
    Thomas Roth
    David Michelson
    Psychopharmacology, 2017, 234 : 1703 - 1711
  • [22] Sustained Clinical Benefits Following OnabotulinumtoxinA Treatment in Patients with Chronic Migraine: A Post Hoc Analysis of the Pooled PREEMPT Studies
    Dodick, D. W.
    Diener, H.
    Silberstein, S. D.
    Yedigarova, L.
    Lipton, R. B.
    HEADACHE, 2020, 60 : 26 - 26
  • [23] SUSTAINED CLINICAL BENEFITS FOLLOWING ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH CHRONIC MIGRAINE: A POST HOC ANALYSIS OF THE POOLED PREEMPT STUDIES
    Dodick, David W.
    Diener, Hans-Christoph
    Silberstein, Stephen D.
    Yedigarova, Larisa
    Lipton, Richard B.
    CEPHALALGIA, 2020, 40 : 92 - 93
  • [24] Benefits of tiotropium/olodaterol compared with tiotropium in patients receiving COPD LAMA at baseline: pooled analysis of 4 clinical trials
    Buhl, R.
    Singh, D.
    de la Hoz, A.
    Voss, F.
    Ferguson, G. T.
    PNEUMOLOGIE, 2020, 74 : S69 - S70
  • [25] Benefits of tiotropium/olodaterol compared with tiotropium in patients with COPD receiving only A at baseline: pooled analysis of 4 clinical trials
    Buhl, Roland
    Singh, Dave
    De La Hoz, Alberto
    Voss, Florian
    Ferguson, Gary T.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [26] Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network
    Pott, Henrique
    Andrew, Melissa K.
    Shaffelburg, Zachary
    Nichols, Michaela K.
    Ye, Lingyun
    Elsherif, May
    Hatchette, Todd F.
    Leblanc, Jason J.
    Ambrose, Ardith
    Boivin, Guy
    Bowie, William
    Johnstone, Jennie
    Katz, Kevin
    Lagace-Wiens, Phillipe
    Loeb, Mark
    Mccarthy, Anne
    Mcgeer, Allison
    Poirier, Andre
    Powis, Jeff
    Richardson, David
    Semret, Makeda
    Smith, Stephanie
    Smyth, Daniel
    Stiver, Grant
    Trottier, Sylvie
    Valiquette, Louis
    Webster, Duncan
    Mcneil, Shelly A.
    Canadian Immunization Res Network CIRN
    Toronto Invasive Bacterial Dis Network TIBDN
    OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (02):
  • [27] Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials
    Hebert, Adelaide A.
    Albareda, Nuria
    Rosen, Theodore
    Torrelo, Antonio
    Grimalt, Ramon
    Rosenberg, Noah
    Zsolt, Ilonka
    Masramon, Xavier
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (10) : 1051 - 1057
  • [28] Substantial clinical benefits with odevixibat treatment across progressive familial intrahepatic cholestasis genetic deficiencies: subgroup analysis of serum bile acids, pruritus, and safety using pooled data from the PEDFIC 1 and 2 studies
    Thompson, Richard
    Horn, Patrick
    Houwen, Roderick H. J.
    Lacaille, Florence
    Ni, Quanhong
    Stein, Philip
    Tessier, Mary Elizabeth
    Thompson, Carrie
    Vittorio, Jennifer
    Kjems, Lise
    JOURNAL OF HEPATOLOGY, 2021, 75 : S684 - S685
  • [29] Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Forman, Seth B.
    Thaci, Diamant
    Kuligowski, Michael E.
    Venturanza, May E.
    Sun, Kang
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB160 - AB160
  • [30] Clinical Profile of Suvorexant for the Treatment of Insomnia Over 3 Months in Men and Women: Gender Subgroup Analysis of Pooled Phase-3 Data
    Herring, William
    Connor, Kathryn
    Snavely, Duane
    Zhang, Ying
    Snyder, Ellen
    Lines, Christopher
    Michelson, David
    NEUROLOGY, 2016, 86
12345